Literature DB >> 11063251

Localization of the mouse kidney disease (kd) gene to a YAC/BAC contig on Chromosome 10.

K M Dell1, Y X Li, M Peng, E G Neilson, D L Gasser.   

Abstract

Mice that are homozygous for the kidney disease (kd) gene on Chromosome (Chr) 10 spontaneously develop a progressive and fatal interstitial nephritis. The disease phenotype is similar to that of the human disease, juvenile nephronophthisis. Using a backcross and intercross breeding strategy and analysis of over 900 resultant progeny, this genetic locus has now been mapped to a minimal co-segregating region of approximately two megabases between D10Mit 193 and D10Mit 38. The location assigned to kd by this study is over 3 cM from the current Mouse Genome Database location. The entire interval has been cloned in yeast artificial chromosome (YAC) and bacterial artificial chromosome (BAC) clones. Recombinant analysis has permitted assignment of 13 Mit microsatellite markers to positions near or within the region. Two new markers have been identified by using single-strand conformation polymorphism (SSCP) analysis of sequenced BAC ends. Several BAC end sequences align with human BAC clones from Chr 6q2 that contain NR2E1. Snx3, and Ros1. Three murine genes, CD24a, fyn, and ColX reported to map in or near the kd region as defined by this study have been evaluated. Though not definitely excluded, they appear to be unlikely candidates.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11063251     DOI: 10.1007/s003350010188

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  8 in total

1.  Inhibiting cytosolic translation and autophagy improves health in mitochondrial disease.

Authors:  Min Peng; Julian Ostrovsky; Young Joon Kwon; Erzsebet Polyak; Joseph Licata; Mai Tsukikawa; Eric Marty; Jeffrey Thomas; Carolyn A Felix; Rui Xiao; Zhe Zhang; David L Gasser; Yair Argon; Marni J Falk
Journal:  Hum Mol Genet       Date:  2015-06-03       Impact factor: 6.150

2.  Parkinson's disease-like neuromuscular defects occur in prenyl diphosphate synthase subunit 2 (Pdss2) mutant mice.

Authors:  Carly G K Ziegler; Min Peng; Marni J Falk; Erzsebet Polyak; Elpida Tsika; Harry Ischiropoulos; Dana Bakalar; Julie A Blendy; David L Gasser
Journal:  Mitochondrion       Date:  2011-10-01       Impact factor: 4.160

3.  The mitochondrial and kidney disease phenotypes of kd/kd mice under germfree conditions.

Authors:  Troy M Hallman; Min Peng; Ray Meade; Wayne W Hancock; Michael P Madaio; David L Gasser
Journal:  J Autoimmun       Date:  2005-12-06       Impact factor: 7.094

4.  Glomerular and tubular epithelial defects in kd/kd mice lead to progressive renal failure.

Authors:  Michael P Madaio; Rexford S Ahima; Ray Meade; Daniel J Rader; Alberto Mendoza; Min Peng; John E Tomaszewski; Wayne W Hancock; David L Gasser
Journal:  Am J Nephrol       Date:  2005-11-09       Impact factor: 3.754

5.  The kd/kd mouse is a model of collapsing glomerulopathy.

Authors:  Laura Barisoni; Michael P Madaio; Maria Eraso; David L Gasser; Peter J Nelson
Journal:  J Am Soc Nephrol       Date:  2005-08-24       Impact factor: 10.121

6.  Mutant prenyltransferase-like mitochondrial protein (PLMP) and mitochondrial abnormalities in kd/kd mice.

Authors:  Min Peng; Leonard Jarett; Ray Meade; Michael P Madaio; Wayne W Hancock; Alfred L George; Eric G Neilson; David L Gasser
Journal:  Kidney Int       Date:  2004-07       Impact factor: 10.612

7.  Focal segmental glomerulosclerosis is associated with a PDSS2 haplotype and, independently, with a decreased content of coenzyme Q10.

Authors:  David L Gasser; Cheryl A Winkler; Min Peng; Ping An; Louise M McKenzie; Gregory D Kirk; Yuchen Shi; Letian X Xie; Beth N Marbois; Catherine F Clarke; Jeffrey B Kopp
Journal:  Am J Physiol Renal Physiol       Date:  2013-08-07

8.  Probucol ameliorates renal and metabolic sequelae of primary CoQ deficiency in Pdss2 mutant mice.

Authors:  Marni J Falk; Erzsebet Polyak; Zhe Zhang; Min Peng; Rhonda King; Jonathan S Maltzman; Ezinne Okwuego; Oksana Horyn; Eiko Nakamaru-Ogiso; Julian Ostrovsky; Letian X Xie; Jia Yan Chen; Beth Marbois; Itzhak Nissim; Catherine F Clarke; David L Gasser
Journal:  EMBO Mol Med       Date:  2011-06-08       Impact factor: 12.137

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.